General Healthcare News
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody,...
Leica Biosystems and Indica Labs: Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to clinical...
DEA addressed the status of telemedicine prescribing flexibilities including state reciprocity (DEA-DC-018 EO-DEA067) and medications for opioid use disorder prescribed by telephone (DEA-DC-022 EO-DEA068) in the temporary rule titled "Temporary...
New from GE HealthCare: Innovations include Health Companion research project powered by agentic AI Additional early innovations explore pressing care needs, including identifying new ways to detect breast cancer and improving...
From the Mikroscan Blog: On The Path In the ever-evolving landscape of medical technology, digital pathology continues to make significant strides. The American Medical Association (AMA) has recently unveiled its plans for the year 2024,...
CND Biomarker Testing Services Utilizing Groundbreaking NerValence™ System Unveiled at the AD/PD™ 2024 Parkinson's and Alzheimer's Disease Conference SCOTTSDALE, Ariz.., March 5, 2024 /PRNewswire/ -- CND Life Sciences (CND), a...
